
|Articles|May 1, 2008
- LCGC North America-05-01-2008
- Volume 26
- Issue 5
Peaks of Interest- Thar Expands Team in Europe
Thar Instruments (Pittsburgh, Pennsylvania) has expanded their European team by four new members since the company's acquisition of Berger SFC in 2007.
Advertisement
Thar Instruments (Pittsburgh, Pennsylvania) has expanded their European team by four new members since the company's acquisition of Berger SFC in 2007.
Thar began hiring with two technical and applications support positions and a new head of customer service for the UK, Ireland, Spain, and France. Finally, a technical sales and applications support position was created to aid customers in France, Switzerland, and Italy.
Articles in this issue
over 18 years ago
New Gas Chromatography Products at Pittcon 2008over 18 years ago
How Do I . . . ?over 18 years ago
Lab Spray Dryersover 18 years ago
2008 Method Validation Surveyover 18 years ago
Peaks of Interest-PerkinElmer Announces Young Chromatographer AwardAdvertisement
Related to this article

Automated sequential tube sampling and chemometrics supplement GC–MS, adding time profiling and fast product-line comparison for real-world insight.

Revisiting insertion distance for methanol and methylene chloride in GC analysis and confirming that insertion depth strongly affects response and reproducibility.

A novel SFC–QTOF-MS method accurately detected 10 drugs in oral fluid, matching LC–MS/MS in 83 DUID cases while reducing run time by 42% and organic solvent use by 81%.

Ultrahigh-performance liquid chromatography–tandem mass spectrometry (UHPLC–MS/MS) shows flonicamid residues in rice pose negligible dietary risk.

Meet the expert panel exploring the challenges involved in GLP-1 analysis in this LCGC International Peer Exchange®.

High-performance liquid chromatography-tandem mass spectroscopy (HPLC–MS/MS) chromatography reveals pyrrolizidine alkaloids (PA)/pyrrolizidine alkaloid N-oxides (PANO) toxin risks in 63 tea samples.

Advances in DNA/RNA chromatography columns led to stable, pure mRNA production, supporting the development of COVID-19 vaccines rapidly.
Advertisement
Advertisement

